InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-8.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Arrow Alexander K., Chief Financial Officer. Insider active across 1 company, notably Protagenic Therapeutics, Inc.\new. In total, 4 filings have been published. Split: 4 buys · 0 sell. Total volume traded: €25k. History available since 29 April 2021. The latest transaction was disclosed on 12 October 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
8,000 shares@ US$0.8124.2% of flowPTIX Common StockSEC:0001493152-23-037136:0
Ideal exit: 8 Jul 2024 (T+270)
23,000 shares@ US$0.711.32% mcap80.4% of flowPTIX Common StockSEC:0001493152-22-014338:0
Ideal exit: 11 Feb 2023 (T+270)
1,000 shares@ US$2.299.8% of flowPTIX Common StockSEC:0001493152-21-010335
Ideal exit: 24 Jan 2022 (T+270)
1,000 shares@ US$2.290.16% mcap9.8% of flowPTIX Common StockSEC:0001493152-21-010335:0
Ideal exit: 24 Jan 2022 (T+270)
4 of 4 declarations
About Arrow Alexander K.
Arrow Alexander K. is the Chief Financial Officer at Protagenic Therapeutics, Inc. In this role, he oversees the company's financial operations and is involved in strategic decision-making. His expertise in finance allows him to effectively manage financial resources and optimize the company's performance. He collaborates with other executives to ensure growth and profitability.
